Dr. Ravindra Uppaluri is the Chief  of Otolaryngology at Brigham and Women’s Hospital (BWH). He has dedicated his career to the pursuit of innovative approaches that advance outcomes for head and neck cancer patients. His surgical interests encompass minimally invasive approaches to head and neck cancers, including transoral access to reduce morbidity and novel surgical approaches of the anterior skull base.

His research focus has been on high fidelity preclinical modeling of head and neck cancers and directly studying patients afflicted with this disease. His laboratory work, which is funded by the National Institute of Health (NIH), has leveraged genomic approaches, novel model systems, and leading-edge therapeutics to more clearly define oral squamous cell head and neck cancer dependencies.

Another major area of his research efforts has been in immunotherapy, specifically identifying the determinants of immunotherapy success in patients with head and neck cancers.

A graduate of Carleton College, Dr. Uppaluri received his medical degree and doctorate in genetics from the University of Minnesota before completing his surgical internship and residency in otolaryngology at the Washington University School of Medicine/Barnes-Jewish Hospital.